Neuren Pharmaceuticals LimitedASX: NEU

Phase 3 trial of trofinetide in Rett syndrome commences

Oct 31, 2019 at 2:36 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment